A randomized, controlled study comparing the effects of vestipitant or vestipitant and paroxetine combination in subjects with tinnitus

Otology and Neurotology

Volumn 32, Issue 5, 2011, Pages 721-727

  Roberts, Claire ^a   Inamdar, Amir ^a   Koch, Annelize ^b   Kitchiner, Pauline ^b   Dewit, Odile ^b   Merlo Pich, Emilio ^c   Fina, Paolo ^c   McFerran, Don J ^d   Baguley, David M ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c GSK   (Italy)

^d ESSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

Neurokinin; Paroxetine; Randomized controlled trial; Selective serotonin reuptake inhibitor; Substance PVTinnitus; Vestipitant

Indexed keywords

NEUROKININ 1 RECEPTOR; PAROXETINE; PIPERIDINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; VESTIPITANT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TINNITUS; TREATMENT OUTCOME;

CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; PIPERIDINES; RECEPTORS, NEUROKININ-1; SEROTONIN UPTAKE INHIBITORS; TINNITUS; TREATMENT OUTCOME;

EID: 79960004946     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e318218a086     Document Type: Article

References (22)

1. McFadden D. Tinnitus. Facts, Theories, and Treatments. Washington, DC: National Academy Press, 1982.
2. Holgers KM, Håkansson BE. Sound stimulation via bone conduc-tion for tinnitus relief: a pilot study. Int JAudiol 2002;41:293-300. (Pubitemid 37408435)
3. Davis A, El Rafaie A. Epidemiology of tinnitus. In: Tyler RS, ed. Tinnitus Handbook. San Diego, CA: Singular, 2000;1-23.
4. Baguley DM. What progress have we made with tinnitus? The Tonndorf Lecture 2005. Acta Otolaryngol Suppl 2006;556:4-8.
5. Bárány R. Die beeinflussung des ohrensausens durch intravenös injizierte lokalanästhetica. Acta Otolaryngologica 1935;23:201-203.
6. den Hartig J, Hilders CGJM, Schoemaker RC, Hulsohof JH, Cohen AF, Vermeij P. Tinnitus suppression by intravenous lido-caine in relation to its plasma concentration. Clin Pharmacol Ther 1993;54:415-20. (Pubitemid 23316178)
7. Baguley DM, Jones S, Wilkins I, Axon PR, Moffat DA. The inhibitory effect of intravenous lidocaine infusion on tinnitus after translabyrinthine removal of vestibular schwannoma: a double-blind, placebo-controlled, crossover study. Otol Neurotol 2005;26: 169-76. (Pubitemid 40418648)
8. Simpson JJ, Gilbert AM, Weiner GM, Davies WE. The assessment of lamotrigine, an antiepileptic drug in the treatment of tinnitus. Am J Otol 1999;20:627-31. (Pubitemid 30120079)
9. McKenna L, Hallam RS, Hinchcliffe R. The prevalence of psycho-logical disturbance in neuro-otology outpatients. Clin Otolaryngol AlliedSci 1991;16:452-6.
10. Wang HT, Luo B, Huang YN, Zhou KQ, Chen L. Sodium salicylate suppresses serotonin-induced enhancement of GABAergic sponta-neous inhibitory postsynaptic currents in rat inferior colliculus in vitro. Hear Res 2008;236:42-51.
11. Darlington CL, Smith PF. Drug treatments for tinnitus. Prog Brain Res 2007;166:249-62. (Pubitemid 47588073)
12. Hafidi A, Beurg M, Bouleau Y, Dulon D. Comparative distribution of NK1, NK2, and NK3 receptors in the rat brainstem auditory nuclei. Brain Res 2002;947:299-306.
13. McCabe C, Cowen PJ, Harmer CJ. NK1 receptor antagonism and the neural processing of emotional information in healthy volun-teers. Int J Neuropsychopharmacol 2009;12:1261-74.
14. Sabbatini FM, Fabio RD, Griffante C, et al. Synthesis and phar-macological characterization of constrained analogues of Vestipi-tant as in vitro potent and orally active NK(1) receptor antagonists. Bioorg Med Chem Lett 2010;20:623-7.
15. Brocco M, Dekeyne A, Mannoury la Cour C, et al. Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents. Eur Neuro-psychopharmacol 2008;18:729-50.
16. Newman CW, Jacobson GP, Spitzer JB. Development of the Tin-nitus Handicap Inventory. Arch Otolaryngol Head Neck Surg 1996;122:143-8.
17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. (Pubitemid 13098606)
18. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): apsychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54: 573-83. (Pubitemid 37289444)
19. Erratum in: BiolPsychiatry 2003;54:585.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th ed. Washington, DC: American Psychiatric Association, 1994.
21. Zoger S, Svedlund J, Holgers KM. The effects of sertraline on severe tinnitus suffering: a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 2006;26:32-9. (Pubitemid 43167088)
22. Robinson SK, Viirre ES, Bailey KA, Gerke MA, Harris JP. Randomized placebo-controlledtrial of a selective serotonin reuptake inhibitor in the treatment of non depressed tinnitus subjects. Psy-chosom Med 2005;67:981-8. (Pubitemid 43740113)